StockNews.AI
REPL
StockNews.AI
16 hrs

Class Action Filed Against Replimune Group, Inc. (REPL) Seeking Recovery for Investors - Contact The Gross Law Firm

1. Replimune faces a class action lawsuit for allegedly misleading statements. 2. The lawsuit claims overstatements about the IGNYTE trial led to investor losses. 3. Shareholders from November 2024 to July 2025 are encouraged to participate. 4. The law firm's deadline for lead plaintiff appointment is September 22, 2025. 5. Class action notices may increase scrutiny of Replimune's business practices.

8m saved
Insight
Article

FAQ

Why Bearish?

The class action alleges misleading statements affecting investor trust and stock value, similar to previous cases causing declines in Biopharma stocks post-litigations.

How important is it?

The severity of the allegations and the potential for significant financial impact on shareholders make this highly relevant.

Why Short Term?

Immediate impacts are expected as the lawsuit progresses and could lead to a rapid change in investor sentiment.

Related Companies

NEW YORK, Aug. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ:REPL).

Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/replimune-group-inc-loss-submission-form-3/?id=163017&from=4

CLASS PERIOD: November 22, 2024 to July 21, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) defendants recklessly overstated the IGNYTE trial's prospects, given material issues that defendants knew or should have known of, which resulted in the FDA deeming the IGNYTE trial inadequate and not well-controlled; and (2) as a result, defendants' statements about Replimune's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: September 22, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/replimune-group-inc-loss-submission-form-3/?id=163017&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of REPL during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 22, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm

15 West 38th Street, 12th floor

New York, NY, 10018

Email: dg@securitiesclasslaw.com

Phone: (646) 453-8903

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/class-action-filed-against-replimune-group-inc-repl-seeking-recovery-for-investors--contact-the-gross-law-firm-302537020.html

SOURCE The Gross Law Firm

Related News